Compounds for degrading alpha-synuclein aggregates and uses thereof
US12377152B2 · kind B2 · utility
0Cited by
18References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2022 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Apr 1, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compounds, compositions and methods useful for the treatment of neurodegenerative diseases, in particular synucleinopathies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.